By Associate Professor Miriam Tania Levy

Preprints

Joseph Yeoh YK; Dore GJ; Lockart I; Danta M; Flynn C; Blackmore C; Levy MT; George J; Alavi M; Hajarizadeh B, 2023, Temporal change in etiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients with hepatocellular carcinoma in New South Wales, Australia, http://dx.doi.org/10.1101/2023.02.20.23286164

Patwala K; Prince DS; Celermajer Y; Alam W; Paul E; Strasser SI; McCaughan GW; Gow P; Sood S; Murphy E; Roberts S; Freeman E; Stratton E; Davison SA; Levy MT; Clark-Dickson M; Nguyen V; Bell S; Nicoll A; Bloom A; Lee AU; Ryan M; Howell J; Valaydon Z; Mack A; Liu K; Dev A, 2022, Lenvatinib for the treatment of hepatocellular carcinoma - a real-world multicentre Australian cohort study, http://dx.doi.org/10.21203/rs.3.rs-1714922/v1

Back to profile page